P-IS-29 TACC3 is a novel target of paclitaxel; Its implication in paclitaxel-mediated tumor therapy(Oncology 8,Group 95,International Session)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人 日本産科婦人科学会の論文
- 2006-02-01
著者
-
Yim Eun-kyoung
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
-
Bae Jeong-hoon
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
-
Kim Chan-joo
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
-
Namkoong Seong-Eun
Division of Gynecologic Oncology, Department of Obsterics and Gynecology, Catholic University Medica
-
Park Jong-Sup
Division of Gynecologic Oncology, Department of Obsterics and Gynecology, Catholic University Medica
-
Namkoong Seong-eun
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
-
Park Jong-sup
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
関連論文
- P1-IS-40 Treatment of Ovarian Cancer with Paclitaxel- or Carboplatin-Based Intraperitoneal Hyperthermic Chemotherapy during Secondary Surgery
- P-IS-29 TACC3 is a novel target of paclitaxel; Its implication in paclitaxel-mediated tumor therapy(Oncology 8,Group 95,International Session)
- P-IS-9 Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells(Oncology 3,Group 90,International Session)
- P-IS-8 Antiproliferative and antiviral effects by etoposide in HPV-associated cervical cancer cells(Oncology 2,Group 89,International Session)
- P-IS-7 Novel interaction between HPV E6 and BARD1 (BRCA1-associated ring domain 1) and its biologic roles(Oncology 2,Group 89,International Session)
- P-IS-24 Clinical outcome of staging surgery with or without bilateral salpingo-oophorectomy in clinical stage I-II endometrial cancer patients(Oncology 6,Group 93,International Session)